CTOs on the Move

Cardo Medical Inc.

www.cardomedical.com

 
Cardo Medical Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Beverly Hills, CA. To find more information about Cardo Medical Inc., please visit www.cardomedical.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cardomedical.com
  • 9701 Wilshire Blvd Ste 1100
    Beverly Hills, CA USA 90212-2011
  • Phone: 310.274.2036

Executives

Name Title Contact Details

Similar Companies

Pacific Reproductive Svc

Pacific Reproductive Svc is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MaxIT Vitalize an SAIC company

MaxIT Vitalize an SAIC company is a Westfield, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hartford HealthCare

Hartford HealthCare is Connecticut`s most comprehensive healthcare network. With 33,000 employees and total operating revenue of $4.3 billion, Hartford HealthCare has cultivated a strong, unified culture of accountability and innovation. Its care-delivery system, serving 185 towns and cities at more than 400 locations, includes two tertiary-level teaching hospitals, an acute-care community teaching hospital, an acute-care hospital and trauma center, three community hospitals, the state`s most extensive behavioral health network, a large multispecialty physician group, a clinical care organization, a regional home care system, an array of senior care services, and a large physical therapy and rehabilitation network. Hartford HealthCare`s unique, systemwide Institute Model offers a single, high standard of care in crucial specialties at hospital and ambulatory sites across Connecticut. The institutes include: Cancer, Heart and Vascular, Neuroscience, Orthopedics and Urology.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III

Amplivox

Amplivox is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.